Menon Renewable Products was founded with the vision of replacing antibiotics with natural peptides in both humans and animals. Dr. Menon pioneered the production of novel materials, creating a spectrum of unique ultra-small molecule peptides, nucleotides, and enzymes. Over the past decade, these products have disrupted traditional views in immunology, promoting health across various animal species in 15 countries. In recent years, rigorous testing for human applications has demonstrated unprecedented capabilities in reducing A1C levels for individuals with diabetes and mitigating inflammation and allergies.